Preclinical neonatal rat studies of heparin-binding EGF-like growth factor in protection of the intestines from necrotizing enterocolitis.
about
Heparin-binding EGF-like growth factor protects intestinal stem cells from injury in a rat model of necrotizing enterocolitis.Milk epidermal growth factor and gut protection.Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation.Heparin-binding EGF-like growth factor promotes intestinal anastomotic healingIntracellular heat shock protein-70 negatively regulates TLR4 signaling in the newborn intestinal epithelium.Executive summary of the workshop "Nutritional Challenges in the High Risk Infant".The human milk oligosaccharide 2'-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestineHeparin-binding epidermal growth factor-like growth factor improves intestinal barrier function and reduces mortality in a murine model of peritonitis.Heparin-binding EGF-like growth factor (HB-EGF) protects the intestines from radiation therapy-induced intestinal injury.P-glycoprotein induction by breast milk attenuates intestinal inflammation in experimental necrotizing enterocolitis.ErbB receptors and their growth factor ligands in pediatric intestinal inflammation.The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis.Heparin-binding EGF-like growth factor (HB-EGF) therapy for intestinal injury: Application and future prospects.Pathogenesis of NEC: Role of the innate and adaptive immune response.Deletion of the heparin-binding epidermal growth factor-like growth factor gene increases susceptibility to necrotizing enterocolitis.Heparin-binding epidermal growth factor-like growth factor overexpression in transgenic mice increases resistance to necrotizing enterocolitis.HB-EGF promotes intestinal restitution by affecting integrin-extracellular matrix interactions and intercellular adhesions.
P2860
Q24629285-826FDC7A-FA39-4AF2-8504-79132B11DEA8Q33781408-45F1E0D7-8DE5-4667-A864-CE24169848EAQ34357451-BB91C9B1-CF90-43C0-93CF-1B65D93EBF81Q34432044-7555C7C1-8D25-471A-8ED7-4BB444FB7527Q35903227-A07A5543-7922-4970-8FA1-7DA23C6AC69BQ35932910-E5AAEC94-1A6A-4C53-9E94-A9C9CD8FDAABQ36127329-584641F7-7416-4F1E-97EE-3431E24B71B2Q36614045-50C49F2E-E7B7-4FB8-AC98-E5B7202713C0Q37009351-43A67811-6134-42F7-8222-1C51E326D58DQ37540633-BFE7F3BD-29EF-4CAA-B13C-F03F34EC64FCQ37734240-94E32070-9932-40BB-BEFA-2FAAAF79DE2CQ38101129-F2AD2127-6AB7-4F3F-B162-C2305C242821Q38380575-4A1DFE73-9D47-4E6B-AB70-710D04D6FBE4Q39035255-7F7723AF-8A99-4076-910D-AABB289C7427Q40033966-CE108B39-BCD2-4DC0-87C4-E6C68563D5DAQ42093441-0946FBF0-3FA7-4DB6-8F48-BECF7C51C0E9Q54458115-542A5C3E-C119-40E4-8D2B-6B43EC8E5241
P2860
Preclinical neonatal rat studies of heparin-binding EGF-like growth factor in protection of the intestines from necrotizing enterocolitis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Preclinical neonatal rat studi ...... rom necrotizing enterocolitis.
@en
type
label
Preclinical neonatal rat studi ...... rom necrotizing enterocolitis.
@en
prefLabel
Preclinical neonatal rat studi ...... rom necrotizing enterocolitis.
@en
P2093
P2860
P1433
P1476
Preclinical neonatal rat studi ...... rom necrotizing enterocolitis.
@en
P2093
Andrei Radulescu
Gail E Besner
Nicholas A Zorko
P2860
P2888
P304
P356
10.1203/PDR.0B013E3181994FA0
P407
P577
2009-04-01T00:00:00Z
P6179
1045703009